Drugs in Palliative Care (Drugs In)

While palliative care has adopted a holistic approach to treatment, medication driven symptom management ostensibly forms the critical aspect of care. Prescribing in palliative care can be extremely complex because the patient may often have comorbidity, or occasionally multimorbidity. The associated polypharmacy further complicates the pharmacological management of symptoms being caused by the palliative condition. This can be daunting for healthcare professionals and can negatively impact upon the effectiveness of care provided.

Fully revised and updated, the third edition of Drugs in Palliative Care provides an accessible and succinct overview of the main drugs that are encountered in palliative care clinical practice. The text begins by providing a clinical pharmacology overview and prescribing guidance, then contains over 160 monographs of palliative care drugs, in an easy to access A-Z format.

• A quick-reference guide to prescribing for palliative care patients.
• Information is presented in a practical and accessible A-Z format for easy navigation.
• Includes a complete revision of all the drugs contained in the book.

New to this Edition:

• The whole book has been reviewed and updated since the last edition.
• New topics include a section on serotonin syndrome; Opioid-Induced Hyperalgesia and Tolerance; QT Interval; Polypharmacy and Deprescribing; and Diabetes in Palliative Care.
• 17 new drug monographs have been introduced that reflect contemporary practice interests.

Detailed contents
Symbols and abbreviations
1: Clinical pharmacology overview
2: Prescribing guidance
3: Drug Monograph A-Z
Index

Andrew Dickman, Consultant Pharmacist, Palliative Care, Academic Palliative and End of Life Care Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK

Dr Andrew Dickman is the Consultant Pharmacist for Palliative Care at the Academic Palliative and End of Life Care Centre, Royal Liverpool University Hospital. He is an honorary Fellow at the University of Liverpool and Honorary Lecturer at the School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University. He has been recently designated as a Fellow of the Royal Pharmaceutical Society for his distinction in the Profession of Pharmacy. As well as numerous papers, Dr Dickman has authored two essential palliative care textbooks, both being highly commended by the BMA.

Contributors:

James Baker, Principal Pharmacist - Medicines Optimisation, Pharmacy Dept, Stepping Hill Hospital, Stockport NHS Foundation Trust, Stockport, UK

RECENZII